Testosterone propionate/testosterone phenylpropionate/testosterone isocaproate/testosterone decanoate
This article needs additional citations for verification. (January 2012) |
Clinical data | |
---|---|
Trade names | Durandrone Forte, Durateston, Prarbolan, Sustanon 250, Sustanon Prolongatum |
Other names | TP/TPP/TiC/TD |
Routes of administration | Intramuscular injection |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider |
Sustanon is a trade name owned by Organon Pharmaceuticals for oil-based injectable blends of esterified testosterone compounds.
Sustanon 250 is a blend of four esterified testosterone compounds: [1]
- 30 mg testosterone propionate
- 60 mg testosterone phenylpropionate
- 60 mg testosterone isocaproate
- 100 mg testosterone decanoate
Sustanon 100 was similar, though with three esters. This smaller dose was usually for pediatric use.
- 20 mg testosterone propionate
- 40 mg testosterone phenylpropionate
- 40 mg testosterone isocaproate
Sustanon 100 has not been produced since 2009.[2]
The different testosterone esters provide for different half-lives. Esterization of the testosterone molecules provides for a sustained (but non-linear) release of testosterone hormone from the injection depot into the blood plasma. [3]
Sustanon 250 is one of the most commonly used testosterone replacement treatments prescribed in the UK,US,Canada and Australia.
This form of testosterone is a popular choice of anabolic steroid among bodybuilders and athletes.[4]
See also
References
- ^ "Sustanon 250, solution for injection". Retrieved 2019-06-15.
- ^ "Discontinuation of Sustanon 100 (testosterone replacement therapy)". NeLM. Archived from the original on 29 September 2009. Retrieved 9 August 2016.
{{cite web}}
: Unknown parameter|deadurl=
ignored (|url-status=
suggested) (help) - ^ "Steroids and SARMS Handbook". Retrieved 2019-06-15.
- ^ "Steroids and SARMS Handbook". Retrieved 2019-06-15.